Austin McCullough
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Austin McCullough has a total of 27 co-authors. Here are the top co-authors by number of shared publications:
- Tammie Lee Smith Benzinger
Mallinckrodt Institute of Radiology, Washington University School of Medicine, St. Louis, MO 63110, USA
3 shared publications Anne M. Fagan
Knight Alzheimer Disease Research Center, Washington University School of Medicine, Saint Louis, MO 63110, USA
2 shared publications- Brian Andrew Gordon
Mallinckrodt Institute of Radiology, Washington University School of Medicine, St. Louis, MO 63110, USA
2 shared publications - David M. Holtzman
Department of Neurology, Hope Center for Neurological Disorders, Knight Alzheimer’s Disease Research Center, Washington University in St. Louis, St. Louis, USA
2 shared publications - Sarah Keefe
Mallinckrodt Institute of Radiology Washington University School of Medicine in St. Louis St. Louis MO USA
2 shared publications - Shaney Flores
Washington University School of Medicine
2 shared publications
Latest Publications
- Open Access
- 25 December 2023
- Published by Wiley in Alzheimer's & Dementia
- Vol. 19 (S16)
Exploring the relationship between genetic patterns and brain properties using the Allen Human Brain Atlas
Background: Imaging transcriptomics is a rapidly developing field that combines neuroimaging with genomics to study mechanisms that influence the organization and activity of the nervous system. Using whole‐brain microarray mRNA expression data from the Allen Human Brain Atlas (AHBA), we examined spatial gradients of gene expression in the brain. We then related these gradients to known spatial patterns of brain function.Method: We mapped regional mRNA expression data from more than 21,000 genes to the 200‐parcel Schaeffer atlas. Principle components analysis (PCA) was used to reduce the dimensionality of the data to ten principle components (PCs). This was done for all genes for the whole brain (WBExp) as well as those specific to Alzheimer Disease (ADExp). We additionally mapped eight other properties: functional connectivity gradients (Fig. 2A), myelin, cortical thickness, cerebral blood volume, cerebral blood flow, glucose consumption, and evolutionary expansion (Fig. 2B) to this atlas to explore their relationships with genetic patterns. Region weights from the PCs were predicted from these eight maps.Result: The majority of variance for both WBExp (Fig. 1A & 1C) and ADExp (Fig. 1B & 1D) expression was explained by three PCs. Functional connectivity gradients one (β = ‐0.38, β = 0.14), two (β = 0.33, β = ‐0.45), and five (β = ‐0.44, β = 0.32) were moderately related to the first PC of WBExp (Fig. 3A) and ADExp (Fig. 3C) expression patterns (p < 0.05), respectively. Cortical thickness (β = ‐0.32, β = 0.19), cerebral brain volume (β = 0.10, β = ‐0.13), cerebral blood flow (β = 0.42, β = ‐0.52), and evolutionary expansion (β = 0.08, β = ‐0.20) were additionally moderately related to the the WBExp PC1 (Fig. 3B, p < 0.05) and the ADExp PC1 (Fig. 3D, p < 0.05), respectively.Conclusion: Our results highlighted that gradients in genetic expressions are related to functional gradients seen using rs‐fMRI as well as biological properties such as cortical thickness, cerebral blood volume, cerebral blood flow, and evolutionary expansion. These findings shed light on mechanisms that influence the structure and function of the brain. Understanding the relationship between genetic patterns and these properties can give insight into healthy and diseased‐brain states such as Alzheimer disease.
- 25 December 2023
- Published by Wiley in Alzheimer's & Dementia
- Vol. 19 (S16)
Open AccessExploring the relationship between genetic patterns and brain properties using the Allen Human Brain Atlas
Background: Imaging transcriptomics is a rapidly developing field that combines neuroimaging with genomics to study mechanisms that influence the organization and activity of the nervous system. Using whole‐brain microarray mRNA expression data from the Allen Human Brain Atlas (AHBA), we examined spatial gradients of gene expression in the brain. We then related these gradients to known spatial patterns of brain function.Method: We mapped regional mRNA expression data from more than 21,000 genes to the 200‐parcel Schaeffer atlas. Principle components analysis (PCA) was used to reduce the dimensionality of the data to ten principle components (PCs). This was done for all genes for the whole brain (WBExp) as well as those specific to Alzheimer Disease (ADExp). We additionally mapped eight other properties: functional connectivity gradients (Fig. 2A), myelin, cortical thickness, cerebral blood volume, cerebral blood flow, glucose consumption, and evolutionary expansion (Fig. 2B) to this atlas to explore their relationships with genetic patterns. Region weights from the PCs were predicted from these eight maps.Result: The majority of variance for both WBExp (Fig. 1A & 1C) and ADExp (Fig. 1B & 1D) expression was explained by three PCs. Functional connectivity gradients one (β = ‐0.38, β = 0.14), two (β = 0.33, β = ‐0.45), and five (β = ‐0.44, β = 0.32) were moderately related to the first PC of WBExp (Fig. 3A) and ADExp (Fig. 3C) expression patterns (p < 0.05), respectively. Cortical thickness (β = ‐0.32, β = 0.19), cerebral brain volume (β = 0.10, β = ‐0.13), cerebral blood flow (β = 0.42, β = ‐0.52), and evolutionary expansion (β = 0.08, β = ‐0.20) were additionally moderately related to the the WBExp PC1 (Fig. 3B, p < 0.05) and the ADExp PC1 (Fig. 3D, p < 0.05), respectively.Conclusion: Our results highlighted that gradients in genetic expressions are related to functional gradients seen using rs‐fMRI as well as biological properties such as cortical thickness, cerebral blood volume, cerebral blood flow, and evolutionary expansion. These findings shed light on mechanisms that influence the structure and function of the brain. Understanding the relationship between genetic patterns and these properties can give insight into healthy and diseased‐brain states such as Alzheimer disease.
- 16 November 2022
- Published by American Association for the Advancement of Science (AAAS) in Science Translational Medicine
- Vol. 14 (671) , eabl7646
APOE ε4 genotype, amyloid-β, and sex interact to predict tau in regions of high APOE mRNA expression
The apolipoprotein E ( APOE ) ε4 allele is strongly linked with cerebral β-amyloidosis, but its relationship with tauopathy is less established. We investigated the relationship between APOE ε4 carrier status, regional amyloid-β (Aβ), magnetic resonance imaging (MRI) volumetrics, tau positron emission tomography (PET), APOE messenger RNA (mRNA) expression maps, and cerebrospinal fluid phosphorylated tau (CSF ptau 181 ). Three hundred fifty participants underwent imaging, and 270 had ptau 181 . We used computational models to evaluate the main effect of APOE ε4 carrier status on regional neuroimaging values and then the interaction of ε4 status and global Aβ on regional tau PET and brain volumes as well as CSF ptau 181 . Separately, we also examined the additional interactive influence of sex. We found that, for the same degree of Aβ burden, APOE ε4 carriers showed greater tau PET signal relative to noncarriers in temporal regions, but no interaction was present for MRI volumes or CSF ptau 181 . This potentiation of tau aggregation irrespective of sex occurred in brain regions with high APOE mRNA expression, suggesting local vulnerabilities to tauopathy. There were greater effects of APOE genotype in females, although the interactive sex effects did not strongly mirror mRNA expression. Pathology is not homogeneously expressed throughout the brain but mirrors underlying biological patterns such as gene expression.
- 16 November 2022
- Published by American Association for the Advancement of Science (AAAS) in Science Translational Medicine
- Vol. 14 (671) , eabl7646
APOE ε4 genotype, amyloid-β, and sex interact to predict tau in regions of high APOE mRNA expression
The apolipoprotein E ( APOE ) ε4 allele is strongly linked with cerebral β-amyloidosis, but its relationship with tauopathy is less established. We investigated the relationship between APOE ε4 carrier status, regional amyloid-β (Aβ), magnetic resonance imaging (MRI) volumetrics, tau positron emission tomography (PET), APOE messenger RNA (mRNA) expression maps, and cerebrospinal fluid phosphorylated tau (CSF ptau 181 ). Three hundred fifty participants underwent imaging, and 270 had ptau 181 . We used computational models to evaluate the main effect of APOE ε4 carrier status on regional neuroimaging values and then the interaction of ε4 status and global Aβ on regional tau PET and brain volumes as well as CSF ptau 181 . Separately, we also examined the additional interactive influence of sex. We found that, for the same degree of Aβ burden, APOE ε4 carriers showed greater tau PET signal relative to noncarriers in temporal regions, but no interaction was present for MRI volumes or CSF ptau 181 . This potentiation of tau aggregation irrespective of sex occurred in brain regions with high APOE mRNA expression, suggesting local vulnerabilities to tauopathy. There were greater effects of APOE genotype in females, although the interactive sex effects did not strongly mirror mRNA expression. Pathology is not homogeneously expressed throughout the brain but mirrors underlying biological patterns such as gene expression.
- Top Cited Papers
- 9 January 2019
- Published by American Association for the Advancement of Science (AAAS) in Science Translational Medicine
- Vol. 11 (474)
Reduced non–rapid eye movement sleep is associated with tau pathology in early Alzheimer’s disease
Slow wave activity during non–rapid eye movement sleep decreases with disease progression in patients with Alzheimer’s disease.
- 9 January 2019
- Published by American Association for the Advancement of Science (AAAS) in Science Translational Medicine
- Vol. 11 (474)
Top Cited PapersReduced non–rapid eye movement sleep is associated with tau pathology in early Alzheimer’s disease
Slow wave activity during non–rapid eye movement sleep decreases with disease progression in patients with Alzheimer’s disease.